RNXT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.00%

Insider Buying (Last 12 Months): $1,155.00

Insider Selling (Last 12 Months): $0.00

RenovoRx Insider Trading History Chart

RenovoRx Share Price & Price History

^$1.22

▲ +0.02 (1.67%)

As of 04/24/2024 12:40 PM ET

Days: 30 | 90 | 365

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

RenovoRx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/3/2023	Angela Nelms	COO	Buy	1,100	$1.05	$1,155.00	1,100
6/7/2022	Ramtin Agah	Insider	Buy	5,182	$1.93	$10,001.26	6,477
5/19/2022	Shaun Bagai	CEO	Buy	5,500	$2.05	$11,275.00	251,557

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

SEC Filings (Institutional Ownership Changes) for RenovoRx (NASDAQ:RNXT)

3.10% of RenovoRx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

RenovoRx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/9/2024	Nixon Peabody Trust Co.	97,165	$0.22M	0.0%	N/A	0.909%
7/10/2023	Level Four Advisory Services LLC	15,000	$34K	0.0%	+50.0%	0.148%
6/5/2023	Level Four Advisory Services LLC	10,000	$35K	0.0%	N/A	0.099%
1/19/2023	Affinity Capital Advisors LLC	15,259	$36K	0.0%	+35.6%	0.168%
11/10/2022	Cohen Lawrence B	54,121	$0.16M	0.1%	-44.3%	0.597%
8/11/2022	Cohen Lawrence B	97,165	$0.19M	0.1%	+79.5%	1.072%
8/2/2022	Bank of The West	975,000	$1.93M	0.2%	N/A	10.750%
5/13/2022	Cohen Lawrence B	54,121	$0.16M	0.1%	N/A	0.599%
2/3/2022	Cambridge Investment Research Advisors Inc.	14,400	$70K	0.0%	-64.7%	0.162%
11/16/2021	Schonfeld Strategic Advisors LLC	20,569	$0.13M	0.0%	N/A	0.245%
11/16/2021	Two Sigma Securities LLC	17,944	$0.11M	0.0%	N/A	0.214%
11/12/2021	Board of Trustees of The Leland Stanford Junior University	60,863	$0.37M	0.0%	N/A	0.726%
11/2/2021	Cambridge Investment Research Advisors Inc.	40,850	$0.25M	0.0%	N/A	0.487%

Data available starting January 2016

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. The company was founded in 2009 and is headquartered in Los Altos, California.

Today's Range

Now: $1.22

$1.19

$1.22

50 Day Range

MA: $1.39

$1.14

$1.78

52 Week Range

Now: $1.22

$0.53

$3.29

Volume

2,486 shs

Average Volume

58,736 shs

Market Capitalization

$20.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of RenovoRx?: RenovoRx's top insider shareholders include:
Shaun Bagai (CEO)
Ramtin Agah (Insider)
Angela Nelms (COO)
Learn More about top insider investors at RenovoRx.